Construction of a New Tumor Immunity-Related Signature to Assess and Classify the Prognostic Risk of Colorectal Cancer

PURPOSE: Although immunotherapy and checkpoint inhibitors contribute to the treatment of colorectal cancer (CRC), few patients can benefit from these treatments. Therefore, our goal was to develop a marker based on immune-related genes to predict the prognosis of patients with CRC to guide treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaocheng, Yang, Tianxing, Qian, Liping, Zhang, Desheng, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520451/
https://www.ncbi.nlm.nih.gov/pubmed/34675628
http://dx.doi.org/10.2147/IJGM.S325511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520451/
https://www.ncbi.nlm.nih.gov/pubmed/34675628
http://dx.doi.org/10.2147/IJGM.S325511

Ejemplares similares